-
Information about Project 9: Myeloproliferative neoplasias (MPN)
ELN Recommendations for managing MPN
Marchetti, M., Vannucchi, A. M., Griesshammer, M., Harrison, C., Koschmieder, S., Gisslinger, H., ... & Barbui, T. (2022). Appropriate management of polycythaemia vera with cytoreductive drug therapy: European ...
-
Contact Persons in Project 9: Myeloproliferative neoplasias (MPN)
Lead Participants
Name
E-mail
Organisation
Country
T. Barbui
✍
Azienda Ospedaliera ‐ Ospedali Riuniti di
Bergamo
Italy
G. Barosi
✍
IRCCS Policlinico S. Matteo
Italy
J. Kiladjian
✍
Hopital Saint‐Louis, Assistance Publique ‐
...
-
Study Groups of Project 9: Myeloproliferative neoplasias (MPN)
Name of the study group
European LeukemiaNet Eosinophilia Study Group
Disease(s)
Eosinophilia associated chronic myeloproliferative disorders (e. g. idiopathic hypereosinophilic syndrome, chronic eosinophilic leukemia, atypical chronic myel ...
-
Publications
Barbui T, Finazzi G:
When and how to treat essential thrombocythemia
N Engl J Med
2005; 353: 85-6
Subjects: CMPD
Barosi G, Bordessoule D, Briere J, Cervantes F, Demory JL, Dupriez B, Gisslinger H, G ...
-
Project 9: Pregnancy in Chronic myeloproliferative diseases (CMPD)
The management of pregnant patients with essential thrombocythemia (ET) and polycythemia vera (PV) may be problematic. In the literature there are about 300 cases of pregnancies reported in ET and less than 50 pregnancies reported in PV. To reduce the ...
-
Links
Pregnancy in patients with Philadelphia negative chronic myeloproliferative disorders (University Clinic of Ulm / Germany):
http://www.uni-ulm.de/onkologie/pages/studienzentrale.html#formulare
Work Packages: WP09, Physicians
ASH Education - Hematolog ...
-
Recommendations of Project 9: Chronic myeloproliferative diseases (MPN)
Recommendations
Barosi G, Tefferi A, Besses C, Birgegard G, Cervantes F, Finazzi G, Gisslinger H, Griesshammer M, Harrison C, Hehlmann R, Hermouet S, Kiladjian JJ, Kroger N, Mesa R, Mc Mullin MF, Pardanani A, Passamonti F, Samuelsson J, Vannucchi AM ...